Efficacy, tolerability, and safety of teverelix DP in patients with advanced prostate cancer: A multicenter, open‐label, phase 2 trial

Documenti analoghi

• The first clinical experience in prostate cancer salvage cryotherapy
  di: Ulys Albertas
  Pubblicazione: (2013)
• Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study
  di: Takafumi Yanagisawa, et al.
  Pubblicazione: (2024)
• Modern predictors and management of incidental prostate cancer at holmium enucleation of prostate
  di: Eric V. Li, et al.
  Pubblicazione: (2024)
• Does larger prostate size provide protection for cancer specific outcomes in localized prostate cancer
  di: Zain Abedali, et al.
  Pubblicazione: (2024)
• Cutibacterium acnes invades prostate epithelial cells to induce BRCAness as a possible pathogen of prostate cancer
  di: Shingo Ashida, et al.
  Pubblicazione: (2024)